Literature DB >> 8850428

Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.

A Snijders-Keilholz1, R J De Keizer, B M Goslings, E W Van Dam, J T Jansen, J J Broerse.   

Abstract

Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.

Entities:  

Mesh:

Year:  1996        PMID: 8850428     DOI: 10.1016/0167-8140(95)01670-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

2.  Secondary malignancy following radiotherapy for thyroid eye disease.

Authors:  Christopher C Gillis; Eun Hae Chang; Khalid Al-Kharazi; Tom Pickles
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-08

3.  Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Authors:  L Bartalena; C Marcocci; C A Gorman; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

4.  No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED).

Authors:  Nevenka Laban-Guceva; Magdalena Antova; Milco Bogoev
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

Review 5.  Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy.

Authors:  Dane H Slentz; Christine C Nelson; Terry J Smith
Journal:  Expert Opin Investig Drugs       Date:  2020-06-10       Impact factor: 6.206

6.  Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.

Authors:  Anuradha Pradhan; Anasua Ganguly; Milind N Naik; Akshay Gopinathan Nair; Savari Desai; Suryasnata Rath
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

7.  Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.

Authors:  Thomas Weissmann; Sebastian Lettmaier; Anna-Jasmina Donaubauer; Christoph Bert; Manfred Schmidt; Friedrich Kruse; Oliver Ott; Markus Hecht; Rainer Fietkau; Benjamin Frey; Florian Putz
Journal:  Strahlenther Onkol       Date:  2021-04-16       Impact factor: 4.033

8.  [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].

Authors:  M H Seegenschmiedt; L Keilholz; G Gusek-Schneider; S Barth; J Hensen; F Wolf; G O Naumann; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.